Verity & Verity LLC increased its stake in shares of MetLife, Inc. (NYSE:MET - Free Report) by 4.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 238,667 shares of the financial services provider's stock after acquiring an additional 10,097 shares during the quarter. MetLife makes up about 1.8% of Verity & Verity LLC's portfolio, making the stock its 20th largest position. Verity & Verity LLC's holdings in MetLife were worth $19,542,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also recently bought and sold shares of MET. Bradley Foster & Sargent Inc. CT increased its position in MetLife by 5.0% in the 2nd quarter. Bradley Foster & Sargent Inc. CT now owns 3,501 shares of the financial services provider's stock valued at $246,000 after buying an additional 166 shares in the last quarter. Mercer Global Advisors Inc. ADV grew its stake in MetLife by 0.5% in the second quarter. Mercer Global Advisors Inc. ADV now owns 62,120 shares of the financial services provider's stock valued at $4,353,000 after acquiring an additional 317 shares during the period. Meiji Yasuda Asset Management Co Ltd. increased its holdings in shares of MetLife by 2.2% during the second quarter. Meiji Yasuda Asset Management Co Ltd. now owns 21,018 shares of the financial services provider's stock valued at $1,475,000 after acquiring an additional 446 shares in the last quarter. Seven Eight Capital LP acquired a new position in shares of MetLife during the second quarter worth approximately $1,116,000. Finally, Intech Investment Management LLC lifted its holdings in shares of MetLife by 21.4% in the 2nd quarter. Intech Investment Management LLC now owns 39,269 shares of the financial services provider's stock worth $2,756,000 after purchasing an additional 6,930 shares in the last quarter. 94.99% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several equities research analysts have recently commented on MET shares. JPMorgan Chase & Co. boosted their target price on shares of MetLife from $86.00 to $88.00 and gave the stock an "overweight" rating in a research report on Tuesday, January 7th. StockNews.com downgraded MetLife from a "buy" rating to a "hold" rating in a research note on Thursday, January 9th. Jefferies Financial Group raised their target price on MetLife from $89.00 to $95.00 and gave the company a "buy" rating in a report on Friday, September 27th. Wells Fargo & Company decreased their price target on MetLife from $93.00 to $92.00 and set an "overweight" rating for the company in a report on Tuesday, January 14th. Finally, Barclays raised their price objective on MetLife from $90.00 to $96.00 and gave the company an "overweight" rating in a research note on Monday, January 6th. One research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $89.92.
Get Our Latest Research Report on MET
MetLife Stock Performance
Shares of NYSE:MET traded up $0.94 during midday trading on Friday, reaching $86.83. 5,168,506 shares of the company's stock traded hands, compared to its average volume of 2,672,899. MetLife, Inc. has a one year low of $64.61 and a one year high of $89.05. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16. The stock has a 50 day moving average of $83.41 and a 200 day moving average of $79.47. The company has a market cap of $60.12 billion, a price-to-earnings ratio of 17.51, a P/E/G ratio of 0.59 and a beta of 1.07.
MetLife Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be issued a dividend of $0.545 per share. The ex-dividend date is Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a yield of 2.51%. MetLife's dividend payout ratio is presently 43.95%.
MetLife Company Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.